HY
Healthy Extracts Inc.
HYEX · OTC
$1.24 +0.03% (+$0.00)
1M -10.79%
Market Cap $18.3M
P/E Ratio -
Div. Yield -
ROE 3.72%
Bulios Fair Price
$1
19.4% downside
Current Price
$1.24
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HYEX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
53 /100
Fair P/S 2.91x
P/B 0.81x
P/FCF 36.53x
Growth
100 /100
Growing Rev. growth 26.08%
Book val. growth 133.88%
EPS growth N/A
Profitability
37 /100
Moderate Gross margin 61.14%
Net margin 13.98%
Op. margin 17.60%
Quality
2 /100
Poor ROIC 3.51%
ROE 3.72%
ROA 2.70%
Debt
42 /100
Moderate Debt/Equity 0.40x
Current ratio 0.20x
Int. coverage -2.92x
Stability
33 /100
Unstable Beta -0.77x
Rev. volatility 17.32%
EPS volatility 125.07%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HYEX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Donald Swanson
Employees
22
Headquarters
Henderson
Upcoming events
17 NOV
Earnings
Upcoming earnings report